JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nibbering, P. H.
Right arrow Articles by Pauwels, E. K.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nibbering, P. H.
Right arrow Articles by Pauwels, E. K.J.

99mTc-Labeled UBI 29-41 Peptide for Monitoring the Efficacy of Antibacterial Agents in Mice Infected with Staphylococcus aureus

Peter H. Nibbering, PhD1, Mick M. Welling, PhD2, Akke Paulusma-Annema1, Carlo P.J.M. Brouwer3, Antonella Lupetti, MD, PhD1,4 and Ernest K.J. Pauwels, PhD2

1 Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands
2 Division of Nuclear Medicine, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
3 AM-Pharma, Bunnik, The Netherlands
4 Dipartimento di Patologia Sperimentale, Biotecnologie Mediche, Infettivologia ed Epidemiologia, Università degli Studi di Pisa, Pisa, Italy



View larger version (19K):

[in a new window]
 
FIGURE 1. (A) Mice infected with S. aureus were injected subcutaneously with various doses of cloxacillin. Accumulation of 99mTc-UBI 29-41 in the infected thigh muscles of untreated (open bars) mice or animals treated with 5 mg/kg (closed bars), 50 mg/kg (horizontally hatched bars), or 500 mg/kg (diagonally hatched bars) cloxacillin is expressed as T/NT (plus SEM) of at least 4 mice. (B) Mice infected with S. aureus were injected subcutaneously with erythromycin. Accumulation of 99mTc-UBI 29-41 in the infected thigh muscles of untreated (open bars) mice or animals treated with 10 mg/kg erythromycin (closed bars) is expressed as T/NT (plus SEM) of at least 4 mice. (C) Rats infected with antibiotic-resistant S. aureus were injected intravenously with various doses of hLF 1-11. Accumulation of 99mTc-UBI 29-41 in the infected thigh muscles of untreated (open bars) rats or animals treated with 4 µg/kg (closed bars) or 40 µg/kg (horizontally hatched bars) hLF 1-11 is expressed as T/NT (plus SEM) of at least 4 rats. *Values that were significantly (P < 0.05) different from those in untreated rats.

 


View larger version (14K):

[in a new window]
 
FIGURE 2. Effect of various doses of cloxacillin (A), erythromycin (B), and hLF 1-11 (C) on the number of viable bacteria in animals infected with S. aureus or antibiotic-resistant S. aureus. Values are means (plus SEM) CFU per gram of thigh muscle at 24 h after injection of the antibacterial agent (n > 4 for each bar). *Values significantly different from those in untreated animals.

 


View larger version (50K):

[in a new window]
 
FIGURE 3. Typical scintigrams of mice with S. aureus infection (A–C) intravenously injected with 2–7 MBq 99mTc-UBI 29-41 after treatment with 50 mg/kg cloxacillin (B), 10 mg/kg erythromycin (C), or no antibiotic (A). In addition, typical scintigrams of rats with antibiotic-resistant S. aureus infection (D and E) intravenously injected with 2–7 MBq 99mTc-UBI 29-41 after treatment with 40 µg/kg hLF 1-11 (E) or no peptide (D). Arrows indicate the infected thigh muscle.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.